To assess the long-term efficacy and safety of single and multiple courses of rituximab therapy in systemic sclerosis (SSc) patients with and without lung disease.
Bosello, S. L., De Luca, G., Rucco, M., Berardi, G., Falcione, M., Danza, F., Pirronti, T., Ferraccioli, G., Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis, <<SEMINARS IN ARTHRITIS AND RHEUMATISM>>, 2015; 44 (4): 428-436. [doi:10.1016/j.semarthrit.2014.09.002] [http://hdl.handle.net/10807/64926]
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis
Bosello, Silvia Laura;De Luca, Giacomo;Rucco, Manuela;Berardi, Giorgia;Falcione, Matteo;Pirronti, Tommaso;Ferraccioli, Gianfranco
2014
Abstract
To assess the long-term efficacy and safety of single and multiple courses of rituximab therapy in systemic sclerosis (SSc) patients with and without lung disease.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
